Back to Authors

Sarmiento, Juan M.

https://orcid.org/0000-0002-1874-6658

Mayo Clinic

Mayo Clinic

Citations 5

Is cytomegalovirus infection related to mycophenolate mofetil after kidney transplantation?1
Munn, Stephen, Payá, Carlos V., Velosa, Jorge A., Nguyen, Justin H. , Sarmiento, Juan M.

Clinical Transplantation | September 30, 2024 | Volume: 12 | Issue: 5 | Pages: 371-374

10.1111/j.1399-0012.1998.tb00983.x Get It

Three multicenter studies have shown that the addition of mycophenolate mofetil (MMF) to an immunosuppressive regime consisting of cyclosporin A (CSA) and prednisone (PRED) decreases the incidence of acute rejection episodes when compared with azathioprine (AZA) or placebo (1–3). In those patients receiving 3 g/d of MMF, the highest dose used in the studies, there was a trend towards an increased incidence of cytomegaloviral sepsis (CMV). We postulated therefore that MMF may represent an independent risk factor for the development of CMV infection in patients receiving renal allografts and MMF at our institution. Having altered the triple drug regime from CSA, AZA (2‐2.5 mg/kg/d) and PRED to CSA. MMF (2 g/d) and PRED in July 1995, we elected to study all patients undergoing kidney transplantation for the 33‐month period January 1994‐September 1996, by undertaking a case control analysis to determine independent risk factors for the development of CMV infection, as defined by CMV viremia or tissue‐invasive CMV. Three CMV disease‐free control patients were matched to each case, these patients having been randomly selected from the entire pool of patients in the observation period. There were 31 CMV case patients and 102 control patients. Univariate analysis indicated that gender, a concomitant pancreas transplant, acute rejection and CMV seropositivity in the donor were risk factors. However, multivariate analysis indicated that only acute rejection and donor CMV seropositivity were independently linked (p<0.05) to CMV disease in this sample. Specifically, the odds ratio (OR) for CMV disease between MMF and AZA was 1.0 (95% confidence interval (CI): 0.46‐2.18). Therefore, in this case control study we find no evidence that MMF at a dose of 2 g/d is an independent risk factor for primary CMV viremia or tissue invasion in renal allograft recipients.
Hepatic Surgery for Metastatic Gastrointestinal Neuroendocrine Tumors
Que, Florencia G., Sarmiento, Juan M. , Nagorney, David M.

Cancer Control | August 30, 2017 | Volume: 9 | Issue: 1 | Pages: 67-79

10.1177/107327480200900111 Get It

Ileal pouch–anal anastomosis and liver transplantation for ulcerative colitis complicated by primary sclerosing cholangitis
Mathis, Kellie L. , Dozois, Eric J. , Sarmiento, Juan M. , Wolff, B. G., Pembérton, John H., Larson, David W. , Cima, Robert R. , Heimbach, Julie K.

British Journal of Surgery | May 21, 2008 | Volume: 95 | Issue: 7 | Pages: 882-886

10.1002/bjs.6210 Get It

Abstract Background The aim was to evaluate outcomes in patients with ulcerative colitis complicated by primary sclerosing cholangitis (PSC) who required ileal pouch–anal anastomosis (IPAA) and orthotopic liver transplantation (OLT). Methods A retrospective analysis was performed of 32 patients undergoing both IPAA and OLT between 1980 and 2006. Data were collected regarding demographics, indication for surgery, postoperative complications, and outcome of IPAA and OLT. Results Thirty-day mortality after either procedure was nil. The median preoperative Model for End-stage Liver Disease (MELD) score for the group with initial IPAA was 8 (range 6–20) and the postoperative score was 11 (range 6–19). At 1 and 10 years, 32 and 26 of the 32 liver grafts had survived, and 31 and 30 of the 32 pouches, respectively. Fourteen patients require daily medical therapy for chronic pouchitis. At a median follow-up of 3·6 (range 0·2–16·2) years after the second of two procedures, responding patients reported a median of 5·5 stools per day and 2 stools per night. Conclusion IPAA and OLT are feasible and safe in patients requiring both procedures for ulcerative colitis and PSC. Functional outcomes are stable over time, despite an increased risk of chronic pouchitis.
Pancreaticoduodenectomy for Islet Cell Tumors of the Head of the Pancreas: Long‐term Survival Analysis
Sarmiento, Juan M. , Farnell, Michael B., Que, Florencia G., Nagorney, David M.

World Journal of Surgery | October 14, 2002 | Volume: 26 | Issue: 10 | Pages: 1267-1271

10.1007/s00268-002-6714-9 Get It

Bullets and Their Role in Sepsis after Colon Wounds
Sarmiento, Juan M. , Yugueros, Patricia, Wolff, Bruce G., Garcı́a, Alberto

World Journal of Surgery | August 25, 2002 | Volume: 21 | Issue: 6 | Pages: 648-652

10.1007/s002689900288 Get It

AbstractThe objective of this study was to determine the relation between the presence of a bullet (gunshot) after injury to the colon and the incidence of sepsis in its track and the soft tissue where it is retained. A retrospective review was carried out of the charts of consecutive patients admitted for abdominal gunshot wounds with proved colon injury during laparotomy where the bullet was either retained in the soft tissue or exited the body. The review covered a period of 4 years beginning January 1, 1990. Three groups were identified for analysis: (1) patients from whom the bullet was surgically removed, with additional cleansing and débridement of the area ( n= 21); (2) patients who did not undergo surgical removal of the bullet (n= 81); and (3) patients in whom the bullet exited spontaneously and in whom only débridement of the skin was carried out (n= 83). Similar risk factors were noted among the groups (age, ATI score, colostomy rate), except for a higher incidence of shock in group 3 (p= 0.003). The incidence of sepsis in soft tissue was least in group 1. It was five and seven times greater in groups 2 and 3, respectively. After an abdominal gunshot with colon injury, the missile should be removed if feasible and the local tissue débrided. If the bullet has exited spontaneously, its internal track must be débrided and lavaged extensively.